MabSwitch™ is an awardee of the 2021 Inspire QuickFire Challenge for Diverse Innovators for its approach to create innovative solutions for patients. The Inspire QuickFire Challenge is a joint program of California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, AbbVie, 5AM Ventures, and Johnson & Johnson Innovation.
“We are deeply honored to be selected as an awardee of the QuickFire Challenge for Diverse Innovators. This is a testament to the innovativeness of our approach to develop regulatable next-generation antibody-based immunotherapies and the potential impact that these can have on vastly improving outcomes of patients suffering from debilitating diseases such as cancer”
Yemi Onakunle Ph.D, MBA – CEO of MabSwitch
Johnson & Johnson announcement
